UV light skin imaging for patchy hair loss
Treatments studied
Part of Skin clinical trials.
This study uses a special UV light to look at your scalp in a new way. It may help doctors better understand and monitor alopecia areata (a condition that causes patchy hair loss). Participation involves only imaging, no drugs or invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have bald patches (plaques) on your scalp that are limited in number and size — not very extensive.
- You are still losing hair actively (hair loss is ongoing).
- Your hair loss started within the last 6 months.
- You have not used any topical, oral, or injected hair loss treatment (except steroid injections) in the past month, and no steroid injections in the past 6 weeks.
- You are not pregnant or breastfeeding, and you do not have a scalp infection or current light therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
This study compares two treatments for patchy hair loss on the scalp: a vitamin D-like cream (calcipotriol) and steroid injections (intralesional steroids). It aims to see which is more effective at regrowing hair in adults with less than half of the scalp affected.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This Phase 2 trial tests dupilumab (an injection medicine) to regrow hair in people with alopecia areata, a condition where the immune system attacks hair follicles. It may help by reducing the immune-related inflammation linked to hair loss.
This trial studies dupilumab (an injection medicine) to help grow hair in children and teens with alopecia areata, an autoimmune hair-loss condition. It aims to see whether the treatment improves hair regrowth compared with usual care over the study period.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.